12 Health Care Stocks Moving In Tuesday's Intraday Session
Portfolio Pulse from Benzinga Insights
Health care stocks experienced significant movement in Tuesday's intraday session. Vaxart, Jin Medical International, Aclaris Therapeutics, Ekso Bionics Holdings, MorphoSys, and Anitra saw their shares rise, with increases ranging from 17.55% to 37.5%. Conversely, Allakos, Accelerate Diagnostics, Atreca, Perspective Therapeutics, ASLAN Pharma, and Avalo Therapeutics experienced declines between 17.49% and 58.5%.
January 16, 2024 | 5:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Allakos' shares fell 58.5% to $1.24, with a market cap of $108.4 million.
The dramatic decline in Allakos' stock price may reflect negative investor sentiment or reactions to adverse company news, likely leading to continued short-term downward pressure.
CONFIDENCE 80
IMPORTANCE 80
RELEVANCE 90
NEGATIVE IMPACT
ASLAN Pharma's stock fell 19.62% to $0.76, with a market cap of $12.6 million.
The decline in ASLAN Pharma's stock price may reflect investor concerns or negative news, which could continue to impact the stock in the short term.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
NEGATIVE IMPACT
Avalo Therapeutics' shares decreased by 17.49% to $4.72, with a market cap of $3.7 million.
Avalo Therapeutics' stock price drop could indicate a lack of investor confidence or adverse developments, likely leading to further short-term declines.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
NEGATIVE IMPACT
Accelerate Diagnostics' shares fell 26.49% to $2.72, with a market cap of $39.5 million.
Accelerate Diagnostics' significant stock price drop could suggest underlying issues or negative market sentiment, which may result in further short-term declines.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
NEGATIVE IMPACT
Atreca's shares fell 26.46% to $0.26, with a market cap of $10.3 million.
The drop in Atreca's stock price may be due to negative investor sentiment or disappointing company developments, which could lead to further short-term depreciation.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
NEGATIVE IMPACT
Perspective Therapeutics' stock fell 25.2% to $0.43, with a market cap of $120.6 million.
Perspective Therapeutics' notable stock price decrease could be a sign of investor worry, potentially leading to further short-term losses.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
POSITIVE IMPACT
Aclaris Therapeutics' stock rose 26.08% to $1.17, with a market cap of $82.5 million.
Aclaris Therapeutics' notable stock price increase could attract more investor interest, potentially leading to a short-term positive impact.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
POSITIVE IMPACT
Anitra's stock rose 17.55% to $1.41, with a market cap of $17.0 million.
Anitra's stock price increase could be a sign of growing investor confidence, possibly leading to further short-term price increases.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
POSITIVE IMPACT
Ekso Bionics Holdings' stock increased 21.55% to $2.03, with a market cap of $30.1 million.
The rise in Ekso Bionics Holdings' shares could indicate a positive market response, potentially leading to further short-term appreciation.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
POSITIVE IMPACT
MorphoSys' stock increased by 20.81% to $10.39, with a market cap of $1.5 billion.
MorphoSys' significant stock price gain suggests a positive investor outlook, which could lead to continued short-term upward momentum.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
POSITIVE IMPACT
Vaxart's stock rose 37.5% to $0.77, with a market cap of $117.0 million.
The significant rise in Vaxart's stock price suggests positive investor sentiment, which could lead to a short-term bullish trend.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
POSITIVE IMPACT
Jin Medical International's stock increased by 31.32% to $106.4, with a market cap of $832.8 million.
The substantial increase in Jin Medical International's stock price may reflect investor confidence and could lead to further short-term gains.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90